https://www.selleckchem.com/pr....oducts/SB-431542.htm
766-0.86 for the modelling cohort and external validation cohort, respectively. Moreover, the calibration of the nomogram showed a nonsignificant Hosmer-Lemeshow test statistic in the modelling (P=0.876) and validation (P=0.802) sets. With respect to decision curve analyses, the nomogram exhibited preferable net benefit gains than the staging system across a wide range of threshold probabilities. The established nomogram displayed a superior performance in terms of predictive accuracy, discrimination capability, and clinical utility
Like
Comment
Share
